https://www.selleckchem.com/pr....oducts/sodium-dichlo
Future research should extend these findings from intentions to behavior. ClinicalTrials.gov Identifier NCT03029286 (date of registration January 24, 2017). In the real-world APPRECIATE study (NCT02740218), most patients with psoriasis demonstrated notable improvements on disease severity measures and reported clinically meaningful treatment benefits with apremilast. We aim to further describe patient-relevant needs and benefits and patient satisfaction with apremilast, including subgroup analyses based on patient cha
Like
Comment
Share
